Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4895-4904

  Zhang, Xuqing ^a   Goel, Tania ^a   Goodfield, Laura L ^a   Muse, Sarah J ^a   Harvill, Eric T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; PERTUSSIS VACCINE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL CLEARANCE; BORDETELLA PERTUSSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE ACCUMULATION; LEUKOCYTE FUNCTION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BORDETELLA PERTUSSIS; CELL LINE; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; LEUKOCYTES; LUNG; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; TIME FACTORS; WHOOPING COUGH;

EID: 79955020418     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000594     Document Type: Article

References (72)

1. Jones, S. A. 2005. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175:3463-3468. (Pubitemid 41292002)
2. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1-78. (Pubitemid 23289250)
3. Lipsky, P. E. 2006. Interleukin-6 and rheumatic diseases. Arthritis Res. Ther. 8 (Suppl 2): S4.
4. Suematsu, S., T. Matsuda, K. Aozasa, S. Akira, N. Nakano, S. Ohno, J. Miyazaki, K. Yamamura, T. Hirano, and T. Kishimoto. 1989. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 86:7547-7551. (Pubitemid 19254493)
5. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253-278. (Pubitemid 20135628)
6. Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. van Hinsbergh, S. Sozzani, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315-325. (Pubitemid 27148598)
7. Mizutani, H., L. T. May, P. B. Sehgal, and T. S. Kupper. 1989. Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6. J. Immunol. 143:896-901. (Pubitemid 19203816)
8. Dienz, O., and M. Rincon. 2009. The effects of IL-6 on CD4 T cell responses. Clin. Immunol. 130:27-33.
9. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
10. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132. (Pubitemid 41541790)
11. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141. (Pubitemid 41541791)
12. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, C. Toniatti, P. Puccetti, F. Bistoni, and V. Poli. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345-1355. (Pubitemid 26134278)
13. Williams, D. M., B. G. Grubbs, T. Darville, K. Kelly, and R. G. Rank. 1998. A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect. Immun. 66:4564-4567. (Pubitemid 28402746)
14. Anguita, J., M. Rincón, S. Samanta, S. W. Barthold, R. A. Flavell, and E. Fikrig. 1998. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J. Infect. Dis. 178:1512-1515.
15. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. Kaufmann. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65:4843-4849. (Pubitemid 27463266)
16. van der Poll, T., C. V. Keogh, X. Guirao, W. A. Buurman, M. Kopf, and S. F. Lowry. 1997. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176:439-444. (Pubitemid 27328767)
17. Sutherland, R. E., J. S. Olsen, A. McKinstry, S. A. Villalta, and P. J. Wolters. 2008. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol. 181:5598-5605.
18. Mattoo, S., and J. D. Cherry. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382. (Pubitemid 40548297)
19. Crowcroft, N. S., C. Stein, P. Duclos, and M. Birmingham. 2003. How best to estimate the global burden of pertussis? Lancet Infect. Dis. 3:413-418. (Pubitemid 36791118)
20. Gilberg, S., E. Njamkepo, I. P. Du Châtelet, H. Partouche, P. Gueirard, C. Ghasarossian, M. Schlumberger, and N. Guiso. 2002. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J. Infect. Dis. 186:415-418. (Pubitemid 34816326)
21. Hodder, S. L., J. D. Cherry, E. A. Mortimer, Jr., A. B. Ford, J. Gornbein, and K. Papp. 2000. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. 31:7-14. (Pubitemid 32268930)
22. Skowronski, D. M., G. De Serres, D. MacDonald, W. Wu, C. Shaw, J. Macnabb, S. Champagne, D. M. Patrick, and S. A. Halperin. 2002. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis. 185:1448-1453. (Pubitemid 34507967)
23. von König, C. H., S. Halperin, M. Riffelmann, and N. Guiso. 2002. Pertussis of adults and infants. Lancet Infect. Dis. 2:744-750. (Pubitemid 35434559)
24. de Melker, H. E., F. G. Versteegh, J. F. Schellekens, P. F. Teunis, and M. Kretzschmar. 2006. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J. Infect. 53:106-113. (Pubitemid 44028673)
25. Mills, K. H. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3:655-677. (Pubitemid 32607761)
26. Kirimanjeswara, G. S., P. B. Mann, and E. T. Harvill. 2003. Role of antibodies in immunity to Bordetella infections. Infect. Immun. 71:1719-1724. (Pubitemid 36368699)
27. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. Mills. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J. Exp. Med. 186:1843-1851. (Pubitemid 27524594)
28. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410. (Pubitemid 23030823)
29. Wolfe, D. N., G. S. Kirimanjeswara, and E. T. Harvill. 2005. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect. Immun. 73:6508-6513. (Pubitemid 41368814)
30. Dunne, A., P. J. Ross, E. Pospisilova, J. Masin, A. Meaney, C. E. Sutton, Y. Iwakura, J. Tschopp, P. Sebo, and K. H. Mills. 2010. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185:1711-1719.
31. Zhang, X., S. E. Hester, M. J. Kennett, A. T. Karanikas, L. Bendor, D. E. Place, and E. T. Harvill. 2011. IL-1R signaling is required to overcome the effects of pertussis toxin and for efficient infection or vaccination induced immunity against Bordetella pertussis. Infect. Immun. 79:527-541.
32. McGuirk, P., B. P. Mahon, F. Griffin, and K. H. Mills. 1998. Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur. J. Immunol. 28:153-163. (Pubitemid 28048286)
33. Kirimanjeswara, G. S., L. M. Agosto, M. J. Kennet, O. N. Bjornstad, and E. T. Harvill, 2005. Pertussis toxin inhibits neutrophil recruitment to inhibit antibody-mediated clearance of Bordetella pertussis. J. Clin. Invest. 115:3594-3601. (Pubitemid 43121848)
34. Leef, M., K. L. Elkins, J. Barbic, and R. D. Shahin. 2000. Protective immunity to Bordetella pertussis requires both B cells and CD4 (+) T cells for key functions other than specific antibody production. J. Exp. Med. 191:1841-1852. (Pubitemid 30390348)
35. Mahon, B. P., M. S. Ryan, F. Griffin, and K. H. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301. (Pubitemid 26403995)
36. Wolfe, D. N., P. B. Mann, A. M. Buboltz, and E. T. Harvill. 2007. Delayed role of tumor necrosis factor-alpha in overcoming the effects of pertussis toxin. J. Infect. Dis. 196:1228-1236. (Pubitemid 47580278)
37. Mahon, B. P., and K. H. Mills. 1999. Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis. Immunol. Lett. 68:213-217. (Pubitemid 29301879)
38. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602. (Pubitemid 28074200)
39. Clemans, D. L., R. J. Bauer, J. A. Hanson, M. V. Hobbs, J. W. St Geme, III, C. F. Marrs, and J. R. Gilsdorf. 2000. Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect. Immun. 68:4430-4440. (Pubitemid 30497708)
40. Khair, O. A., J. L. Devalia, M. M. Abdelaziz, R. J. Sapsford, and R. J. Davies. 1995. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur. Respir. J. 8:1451-1457.
41. Kube, D., U. Sontich, D. Fletcher, and P. B. Davis. 2001. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L493-L502.
42. Mann, P. B., D. Wolfe, E. Latz, D. Golenbock, A. Preston, and E. T. Harvill. 2005. Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect. Immun. 73:8144-8152. (Pubitemid 41740302)
43. Stibitz, S., and M. S. Yang. 1991. Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J. Bacteriol. 173:4288-4296.
44. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
45. Harvill, E. T., A. Preston, P. A. Cotter, A. G. Allen, D. J. Maskell, and J. F. Miller. 2000. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect. Immun. 68:6720-6728. (Pubitemid 32463376)
46. Zhang, X., M. E. Rodríguez, and E. T. Harvill. 2009. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS ONE 4: e6989.
47. Pilione, M. R., and E. T. Harvill. 2006. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect. Immun. 74:1043-1049. (Pubitemid 43185541)
48. Wolfe, D. N., E. M. Goebel, O. N. Bjornstad, O. Restif, and E. T. Harvill. 2007. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussisinduced immunity. Infect. Immun. 75:4972-4979. (Pubitemid 47502169)
49. Mann, P., E. Goebel, J. Barbarich, M. Pilione, M. Kennett, and E. Harvill. 2007. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infect. Immun. 75:3665-3672. (Pubitemid 47040970)
50. Khelef, N., C. M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900. (Pubitemid 24203975)
51. Rodriguez, M. E., S. M. Hellwig, D. F. Hozbor, J. Leusen, W. L. van der Pol, and J. G. van de Winkel. 2001. Fc receptor-mediated immunity against Bordetella pertussis. J. Immunol. 167:6545-6551. (Pubitemid 33081590)
52. Steed, L. L., E. T. Akporiaye, and R. L. Friedman. 1992. Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes. Infect. Immun. 60:2101-2105.
53. Weingart, C. L., G. Broitman-Maduro, G. Dean, S. Newman, M. Peppler, and A. A. Weiss. 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67:4264-4267. (Pubitemid 29357056)
54. Weingart, C. L., and A. A. Weiss. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68:1735-1739. (Pubitemid 30108584)
55. Lenz, D. H., C. L. Weingart, and A. A. Weiss. 2000. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect. Immun. 68:956-959. (Pubitemid 30056561)
56. Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5:971-974. (Pubitemid 41057712)
57. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
58. Bonville, C. A., C. M. Percopo, K. D. Dyer, J. Gao, C. Prussin, B. Foster, H. F. Rosenberg, and J. B. Domachowske. 2009. Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo. BMC Immunol. 10:14.
59. Gentil, K., and E. Pearlman. 2009. Gamma interferon and interleukin-1 receptor 1 regulate neutrophil recruitment to the corneal stroma in a murine model of Onchocerca volvulus keratitis. Infect. Immun. 77:1606-1612.
60. Sun, K., S. L. Salmon, S. A. Lotz, and D. W. Metzger. 2007. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75:1196-1202. (Pubitemid 46385810)
61. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240. (Pubitemid 40189432)
62. Lubberts, E. 2003. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Investig. Drugs 4:572-577. (Pubitemid 36717203)
63. Chung, D. R., D. L. Kasper, R. J. Panzo, T. Chitnis, M. J. Grusby, M. H. Sayegh, and A. O. Tzianabos. 2003. CD4+ T cells mediate abscess formation in intraabdominal sepsis by an IL-17-dependent mechanism. [Published erratum appears in 2003 J. Immunol. 170:4411.] J. Immunol. 170:1958-1963. (Pubitemid 36197415)
64. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, and J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-769. (Pubitemid 41345965)
65. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795. (Pubitemid 41094960)
66. Fedele, G., P. Stefanelli, F. Spensieri, C. Fazio, P. Mastrantonio, and C. M. Ausiello. 2005. Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression. Infect. Immun. 73:1590-1597. (Pubitemid 40470746)
67. Andreasen, C., D. A. Powell, and N. H. Carbonetti. 2009. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS ONE 4: e7079.
68. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-7989. (Pubitemid 44846315)
69. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
70. Dalrymple, S. A., R. Slattery, D. M. Aud, M. Krishna, L. A. Lucian, and R. Murray. 1996. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64:3231-3235. (Pubitemid 26256170)
71. Smolen, J. S., A. Beaulieu, A. Rubbert-Roth, C. Ramos-Remus, J. Rovensky, E. Alecock, T. Woodworth, R. Alten; OPTION Investigators. 2008. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987-997. (Pubitemid 351392039)
72. Yoshio-Hoshino, N., Y. Adachi, C. Aoki, A. Pereboev, D. T. Curiel, and N. Nishimoto. 2007. Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor. Cancer Res. 67:871-875.